CoChat

Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease

Allison, Anthony C., Cacabelos, Ramon, Lombardi, Valter R.M., Álvarez, Xoan A., Vigo, Carmen · 2001 · Progress in Neuro-Psychopharmacology and Biological Psychiatry

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Abstract

In the brains of patients with Alzheimer's disease (AD) signs of neuronal degeneration are accompanied by markers of microglial activation, inflammation, and oxidant damage. The presence of nitrotyrosine in the cell bodies of neurons in AD suggests that peroxynitrite contributes to the pathogenesis of the disease. A drug with antioxidant and anti-inflammatory activity may prevent neuronal degeneration in AD. Celastrol, a plant-derived triterpene, has these effects. In low nanomolar concentrations celastrol was found to suppress the production by human monocytes and macrophages of the pro-inflammatory cytokines TNF-alpha and IL-1beta. Celastrol also decreased the induced expression of class II MHC molecules by microglia. In macrophage lineage cells and endothelial cells celastrol decreased induced but not constitutive NO production. Celastrol suppressed adjuvant arthritis in the rat, demonstrating in vivo anti-inflammatory activity. Low doses of celastrol administered to rats significantly improved their performance in memory, learning and psychomotor activity tests. The potent antioxidant and anti-inflammatory activities of celastrol, and its effects on cognitive functions, suggest that the drug may be useful to treat neurodegenerative diseases accompanied by inflammation, such as AD.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0278-5846(01)00192-0

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 33 references

Research works printed but not linked: 4

  1. Banati, 1993, Early and Rapid de novo Synthesis of Amyloid 3A4-Amyloid Precursor Protein (APP) in Activated Microglia Glia, 9, 199
  2. Lei, 1991, Effects of Celastrol on IL-1 and IL-2 Production, Pharmacol. Clin. Chin. Mat. Med., 7, 15
  3. Lei, 1991, Immune Suppressive Actions of Celastrol, a Triterpene Compound from Tripterygium wilfordii, Pharmacol. Clin. Chin. Mat. Med., 7, 18
  4. Tao, 1987, Prospective, Controlled, Double-blind Crossover trial of T2 (Polyglycosides Extracted from Tripterygium wilfordii Hook F) in the Treatment of Rheumatoid Arthritis, Chin. J. Med., 26, 399

Cited by

See all 377

Metadata

Authors
Allison, A. C., Cacabelos, R., Lombardi, V. R. M., Álvarez, X. A., & Vigo, C.
Corresponding author
Vigo, Carmen
Venue
Progress in Neuro-Psychopharmacology and Biological Psychiatry
Publisher
Elsevier BV
Published
2001-10
Volume
25
Issue
7
Pages
1341-1357
ISSN
0278-5846 (ISSN-L)
OpenAlex
W1974682598
Cited by
376
References
32
Citations by year
2026: 9 · 2025: 9 · 2024: 12 · 2023: 16 · 2022: 15 · 2021: 22 · 2020: 21 · 2019: 26 · 2018: 26 · 2017: 22 · 2016: 27 · 2015: 17 · 2014: 26 · 2013: 14 · 2012: 15
FWCI
3.39
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • Progress in Neuro-Psychopharmacology and Biological Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
celastrol, Alzheimer's disease, triterpenoids, antioxidant activity, anti-inflammatory activity, microglial activation, nitrotyrosine, peroxynitrite, TNF-α, IL-1β, MHC class II expression, nitric oxide, adjuvant-induced arthritis, cognitive function, neurodegeneration
MeSH terms
Alzheimer Disease, Animals, Anti-Inflammatory Agents, Non-Steroidal, Antioxidants, Humans, Triterpenes, Pentacyclic Triterpenes

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease. https://app.cochat.ai/papers/10.1016/s0278-5846(01)00192-0
The paper
Allison, A. C., Cacabelos, R., Lombardi, V. R. M., Álvarez, X. A., & Vigo, C. (2001). Celastrol, a potent antioxidant and anti-inflammatory drug, as a possible treatment for Alzheimer's disease. Progress in Neuro-Psychopharmacology and Biological Psychiatry. https://doi.org/10.1016/s0278-5846(01)00192-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.